42 related articles for article (PubMed ID: 32407952)
1. The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats.
Radzki RP; Bieńko M; Filip R; Pierzynowski SG
J Nutr Health Aging; 2016; 20(6):628-36. PubMed ID: 27273352
[TBL] [Abstract][Full Text] [Related]
2. The Improving Effect and Safety of Probiotic Supplements on Patients with Osteoporosis and Osteopenia: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
Zeng L; Yu G; Yang K; Hao W; Chen H
Evid Based Complement Alternat Med; 2021; 2021():9924410. PubMed ID: 34349831
[TBL] [Abstract][Full Text] [Related]
3. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM;
Endocr Pract; 2010; 16 Suppl 3(Suppl 3):1-37. PubMed ID: 21224201
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.
Khan MS; Muneeb Akhtar SM; Asghar MS
Int J Gynaecol Obstet; 2024 Jun; ():. PubMed ID: 38881196
[No Abstract] [Full Text] [Related]
5. Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Sansai K; Na Takuathung M; Khatsri R; Teekachunhatean S; Hanprasertpong N; Koonrungsesomboon N
Osteoporos Int; 2020 Oct; 31(10):1853-1864. PubMed ID: 32524173
[TBL] [Abstract][Full Text] [Related]
6. Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Inpan R; Na Takuathung M; Sakuludomkan W; Dukaew N; Teekachunhatean S; Koonrungsesomboon N
Osteoporos Int; 2024 Mar; 35(3):413-430. PubMed ID: 37875614
[TBL] [Abstract][Full Text] [Related]
7. CGRP Regulates the Age-Related Switch Between Osteoblast and Adipocyte Differentiation.
Li H; Qu J; Zhu H; Wang J; He H; Xie X; Wu R; Lu Q
Front Cell Dev Biol; 2021; 9():675503. PubMed ID: 34124062
[TBL] [Abstract][Full Text] [Related]
8. Aqueous Extract of
Qin H; Zhao W; Jiao Y; Zheng H; Zhang H; Jin J; Li Q; Chen X; Gao X; Han Y
Front Pharmacol; 2020; 11():581049. PubMed ID: 33708107
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-year ipriflavone treatment on lumbar bone mineral density and bone metabolic markers in postmenopausal women with low bone mass.
Ohta H; Komukai S; Makita K; Masuzawa T; Nozawa S
Horm Res; 1999; 51(4):178-83. PubMed ID: 10474019
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of ipriflavone in postmenopausal women with osteopenia or osteoporosis: A systematic review and meta-analysis.
Hu Q; Long C; Wu D; You X; Ran L; Xu J; O Klineberg E; Huang S; Chen J; Ning N
Pharmacol Res; 2020 Sep; 159():104860. PubMed ID: 32407952
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).
Fujiwara S; Hamaya E; Sato M; Graham-Clarke P; Flynn JA; Burge R
Clin Interv Aging; 2014; 9():1879-93. PubMed ID: 25395843
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
14. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
Alexandersen P; Toussaint A; Christiansen C; Devogelaer JP; Roux C; Fechtenbaum J; Gennari C; Reginster JY;
JAMA; 2001 Mar; 285(11):1482-8. PubMed ID: 11255425
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
